About Avisyn
Avisyn is a Healthcare company based in San Diego (United States) founded in 2016 by Jeffrey Albert, and was acquired by X-Chem in January 2021. Scientific sourcing services are offered by Avisyn as a CRO. Avisyn offers products and services including DEL Screening, ReadiDEL, ReadiBLOX, HITMiner, and ArtemisAI. Its focus areas include Biopharma Outsourcing and Scientific Sourcing. Its competitors include AlphaGroup and The LinkLab.
Company details
Avisyn was founded in 2016 and is headquartered in San Diego, United States. As a contract research organization, focus is placed on scientific sourcing services within the biotechnology sector. Operations involve connecting clients with specialized scientific resources and expertise. Services encompass sourcing of research materials, personnel, and technical support for drug development and related projects. The company serves clients across the United States and potentially internationally.
- Headquarters San Diego, United States
- Founders Jeffrey Albert
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website avisyn.com
- Social LinkedIn X
- Acquired by X-Chem (Jan 2021)
Products & Services of Avisyn
Avisyn offers a comprehensive portfolio of products and services, including DEL Screening, ReadiDEL, ReadiBLOX, HITMiner, and ArtemisAI.
Service for screening DNA-encoded libraries to identify hits.
Pre-built library for rapid drug discovery applications.
Modular blocks for custom medicinal chemistry synthesis.
AI platform for analyzing DEL data and compound mapping.
AI-driven tool for accelerating drug discovery processes.
Investors in Avisyn
Avisyn has secured backing from 1 investor. Prominent investors backing the company include X-Chem.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Small molecule drug discovery platform is provided to researchers. | 2009 | x-chemrx.com | Waltham, United States |
Investor details for Avisyn
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Avisyn
1 people are tracked at Avisyn (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jeffrey Albert | Founder | Leadership |
Complete people profiles for Avisyn
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Avisyn
2 dated milestones of Avisyn across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Avisyn is founded.
- Exit Acquired by X-Chem.
Competitors of Avisyn
Avisyn has 2 listed competitors in our database. They include AlphaGroup and The LinkLab.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alphagroupmedcomm.com | 2005 | King Of Prussia, United States | Medical communication services are provided by AlphaGroup to healthcare professionals. | |||
| thelinklab.com | 2016 | San Francisco, United States | Provides guidance for life science firms on serialization compliance and implementation. |
Detailed competitors of Avisyn
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Avisyn (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avisyn
Avisyn was founded in 2016.
Avisyn is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Avisyn was founded in 2016 and is headquartered in San Diego, United States. As a contract research organization, focus is placed on scientific sourcing services within the biotechnology sector. Operations involve connecting clients with specialized scientific resources and expertise. Services encompass sourcing of research materials, personnel, and technical support for drug development and related projects. The company serves clients across the United States and potentially internationally.
Avisyn's top competitors include AlphaGroup and The LinkLab.
Avisyn offers DEL Screening, ReadiDEL, ReadiBLOX, HITMiner, and ArtemisAI.
Avisyn has 1 investor. Key investors include X-Chem.
Yes. Avisyn was acquired by X-Chem in January 2021.